Literature DB >> 11992252

Mutations in COL6A3 cause severe and mild phenotypes of Ullrich congenital muscular dystrophy.

Ercan Demir1, Patrizia Sabatelli, Valérie Allamand, Ana Ferreiro, Behzad Moghadaszadeh, Mohamed Makrelouf, Haluk Topaloglu, Bernard Echenne, Luciano Merlini, Pascale Guicheney.   

Abstract

Ullrich congenital muscular dystrophy (UCMD) is an autosomal recessive disorder characterized by generalized muscular weakness, contractures of multiple joints, and distal hyperextensibility. Homozygous and compound heterozygous mutations of COL6A2 on chromosome 21q22 have recently been shown to cause UCMD. We performed a genomewide screening with microsatellite markers in a consanguineous family with three sibs affected with UCMD. Linkage of the disease to chromosome 2q37 was found in this family and in two others. We analyzed COL6A3, which encodes the alpha3 chain of collagen VI, and identified one homozygous mutation per family. In family I, the three sibs carried an A-->G transition in the splice-donor site of intron 29 (6930+5A-->G), leading to the skipping of exon 29, a partial reduction of collagen VI in muscle biopsy, and an intermediate phenotype. In family II, the patient had an unusual mild phenotype, despite a nonsense mutation, R465X, in exon 5. Analysis of the patient's COL6A3 transcripts showed the presence of various mRNA species-one of which lacked several exons, including the exon containing the nonsense mutation. The deleted splice variant encodes collagen molecules that have a shorter N-terminal domain but that may assemble with other chains and retain a functional role. This could explain the mild phenotype of the patient who was still ambulant at age 18 years and who showed an unusual combination of hyperlaxity and finger contractures. In family III, the patient had a nonsense mutation, R2342X, causing absence of collagen VI in muscle and fibroblasts, and a severe phenotype, as has been described in patients with UCMD. Mutations in COL6A3 are described in UCMD for the first time and illustrate the wide spectrum of phenotypes which can be caused by collagen VI deficiency.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11992252      PMCID: PMC419991          DOI: 10.1086/340608

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  49 in total

1.  A novel de novo mutation in the triple helix of the COL6A3 gene in a two-generation Italian family affected by Bethlem myopathy. A diagnostic approach in the mutations' screening of type VI collagen.

Authors:  G Pepe; E Bertini; B Giusti; T Brunelli; P Comeglio; B Saitta; L Merlini; M L Chu; G Federici; R Abbate
Journal:  Neuromuscul Disord       Date:  1999-06       Impact factor: 4.296

2.  Reduced collagen VI causes Bethlem myopathy: a heterozygous COL6A1 nonsense mutation results in mRNA decay and functional haploinsufficiency.

Authors:  S R Lamandé; J F Bateman; W Hutchison; R J McKinlay Gardner; S P Bower; E Byrne; H H Dahl
Journal:  Hum Mol Genet       Date:  1998-06       Impact factor: 6.150

Review 3.  The association of nonsense codons with exon skipping.

Authors:  C R Valentine
Journal:  Mutat Res       Date:  1998-09       Impact factor: 2.433

4.  A missense mutation in the alphaB-crystallin chaperone gene causes a desmin-related myopathy.

Authors:  P Vicart; A Caron; P Guicheney; Z Li; M C Prévost; A Faure; D Chateau; F Chapon; F Tomé; J M Dupret; D Paulin; M Fardeau
Journal:  Nat Genet       Date:  1998-09       Impact factor: 38.330

5.  The Peter Emil Becker Award lecture 1998. The saga of congenital muscular dystrophy.

Authors:  F M Tomé
Journal:  Neuropediatrics       Date:  1999-04       Impact factor: 1.947

6.  A heterozygous splice site mutation in COL6A1 leading to an in-frame deletion of the alpha1(VI) collagen chain in an italian family affected by bethlem myopathy.

Authors:  G Pepe; B Giusti; E Bertini; T Brunelli; B Saitta; P Comeglio; A Bolognese; L Merlini; G Federici; R Abbate; M L Chu
Journal:  Biochem Biophys Res Commun       Date:  1999-05-19       Impact factor: 3.575

7.  Missense mutation in a von Willebrand factor type A domain of the alpha 3(VI) collagen gene (COL6A3) in a family with Bethlem myopathy.

Authors:  T C Pan; R Z Zhang; M A Pericak-Vance; R Tandan; T Fries; J M Stajich; K Viles; J M Vance; M L Chu; M C Speer
Journal:  Hum Mol Genet       Date:  1998-05       Impact factor: 6.150

8.  Comprehensive human genetic maps: individual and sex-specific variation in recombination.

Authors:  K W Broman; J C Murray; V C Sheffield; R L White; J L Weber
Journal:  Am J Hum Genet       Date:  1998-09       Impact factor: 11.025

9.  Collagen VI deficiency induces early onset myopathy in the mouse: an animal model for Bethlem myopathy.

Authors:  P Bonaldo; P Braghetta; M Zanetti; S Piccolo; D Volpin; G M Bressan
Journal:  Hum Mol Genet       Date:  1998-12       Impact factor: 6.150

10.  Assignment of the muscle-eye-brain disease gene to 1p32-p34 by linkage analysis and homozygosity mapping.

Authors:  B Cormand; K Avela; H Pihko; P Santavuori; B Talim; H Topaloglu; A de la Chapelle; A E Lehesjoki
Journal:  Am J Hum Genet       Date:  1999-01       Impact factor: 11.025

View more
  45 in total

Review 1.  Animal models of muscular dystrophy.

Authors:  Rainer Ng; Glen B Banks; John K Hall; Lindsey A Muir; Julian N Ramos; Jacqueline Wicki; Guy L Odom; Patryk Konieczny; Jane Seto; Joel R Chamberlain; Jeffrey S Chamberlain
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

2.  Collagen VI microfibril formation is abolished by an {alpha}2(VI) von Willebrand factor type A domain mutation in a patient with Ullrich congenital muscular dystrophy.

Authors:  Leona D Tooley; Laura K Zamurs; Nicola Beecher; Naomi L Baker; Rachel A Peat; Naomi E Adams; John F Bateman; Kathryn N North; Clair Baldock; Shireen R Lamandé
Journal:  J Biol Chem       Date:  2010-08-21       Impact factor: 5.157

3.  Structure of a collagen VI α3 chain VWA domain array: adaptability and functional implications of myopathy causing mutations.

Authors:  Herimela Solomon-Degefa; Jan M Gebauer; Cy M Jeffries; Carolin D Freiburg; Patrick Meckelburg; Louise E Bird; Ulrich Baumann; Dmitri I Svergun; Raymond J Owens; Jörn M Werner; Elmar Behrmann; Mats Paulsson; Raimund Wagener
Journal:  J Biol Chem       Date:  2020-07-21       Impact factor: 5.157

Review 4.  The collagenopathies: review of clinical phenotypes and molecular correlations.

Authors:  Rebekah Jobling; Rohan D'Souza; Naomi Baker; Irene Lara-Corrales; Roberto Mendoza-Londono; Lucie Dupuis; Ravi Savarirayan; L Ala-Kokko; Peter Kannu
Journal:  Curr Rheumatol Rep       Date:  2014-01       Impact factor: 4.592

5.  Recessive COL6A2 C-globular missense mutations in Ullrich congenital muscular dystrophy: role of the C2a splice variant.

Authors:  Rui-Zhu Zhang; Yaqun Zou; Te-Cheng Pan; Dessislava Markova; Andrzej Fertala; Ying Hu; Stefano Squarzoni; Umbertina Conti Reed; Suely K N Marie; Carsten G Bönnemann; Mon-Li Chu
Journal:  J Biol Chem       Date:  2010-01-27       Impact factor: 5.157

Review 6.  The collagen VI-related myopathies Ullrich congenital muscular dystrophy and Bethlem myopathy.

Authors:  Carsten G Bönnemann
Journal:  Handb Clin Neurol       Date:  2011

7.  A homozygous COL6A2 intron mutation causes in-frame triple-helical deletion and nonsense-mediated mRNA decay in a patient with Ullrich congenital muscular dystrophy.

Authors:  Laura Lucarini; Betti Giusti; Rui-Zhu Zhang; Te-Cheng Pan; Cecilia Jimenez-Mallebrera; Eugenio Mercuri; Francesco Muntoni; Guglielmina Pepe; Mon-Li Chu
Journal:  Hum Genet       Date:  2005-06-17       Impact factor: 4.132

Review 8.  Mitochondrial dysfunction and defective autophagy in the pathogenesis of collagen VI muscular dystrophies.

Authors:  Paolo Bernardi; Paolo Bonaldo
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-05-01       Impact factor: 10.005

9.  New molecular mechanism for Ullrich congenital muscular dystrophy: a heterozygous in-frame deletion in the COL6A1 gene causes a severe phenotype.

Authors:  Te-Cheng Pan; Rui-Zhu Zhang; Dominick G Sudano; Suely K Marie; Carsten G Bönnemann; Mon-Li Chu
Journal:  Am J Hum Genet       Date:  2003-07-01       Impact factor: 11.025

10.  Collagen VI glycine mutations: perturbed assembly and a spectrum of clinical severity.

Authors:  Rishika A Pace; Rachel A Peat; Naomi L Baker; Laura Zamurs; Matthias Mörgelin; Melita Irving; Naomi E Adams; John F Bateman; David Mowat; Nicholas J C Smith; Phillipa J Lamont; Steven A Moore; Katherine D Mathews; Kathryn N North; Shireen R Lamandé
Journal:  Ann Neurol       Date:  2008-09       Impact factor: 10.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.